| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2159120 | Radiotherapy and Oncology | 2009 | 7 Pages |
Abstract
This modeling suggests more aggressive treatment through escalation of dose-per-fraction, which may result in substantial gains in local PFS2year. This points towards treatment durations of 3 weeks as being optimal with a BID schedule predicting possible gains in local PFS2year at lower rates of expected late complications than a QD schedule.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Noah B. Arvidson, Deepak Khuntia, Wolfgang A. Tomé,